University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
NCT Number: NCT00267124
The purpose of this study is to determine the effects of exercise and cardiorespiratory fitness on age-related brain changes.
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Kansas City, Kansas, 66160, United States
The mission of the KU Brain Aging Project is to promote healthy brain aging. How the brain changes with age is not well-characterized and even less is known about the factors influencing the rate of brain aging. Thus, we are using MRI scans to examine the structure of the brain in relation to important lifestyle factors. This will allow us to better understand the processes influencing the brain as it ages. In turn, this will help identify specific ways to promote healthy brain aging and, perhaps, prevent the onset of Alzheimer's disease.
Participants complete 4 visits over several months. The first visit entails a clinical evaluation and memory testing involving the use of paper and pencil testing. The second visit is an MRI brain scan which lasts approximately one hour. The third visit involves drawing blood for laboratory testing and blood banking for future lab studies, lasting roughly 4 hours. The glucose tolerance test is administered. The fourth and final visit is an assessment of the participant's metabolism and exercise testing. This visit lasts approximately two hours.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University of Kansas Medical Center
Other
KU Brain Aging Project
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05463731
Alzheimer Disease, Alzheimer's Disease
Chandler, Arizona, United States
View Trial DetailsNCT04426539
Alzheimer Disease, Alzheimer's Disease
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT01315639
Alzheimer Disease, Alzheimer's Disease
Paris, France
View Trial DetailsNCT04445831
Alzheimer Disease, Alzheimer's Disease
Helsinki, Finland
View Trial Details